Capital Research Global Investors 13F, Q4 2025
Capital Research Global · quarter ending 31 December 2025 · filed 11 February 2026 · SEC CIK 1422848
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q4 2025
The 25 largest of 434 positions. Weights are against the whole filed book. Changes are in shares held, against the Q3 2025 filing.
| Company | Ticker | Value | % of book | vs Q3 2025 |
|---|---|---|---|---|
| MICROSOFT CORP | MSFT | $35.46B | 6.5% | unchanged |
| NVIDIA CORPORATION | NVDA | $32.00B | 5.9% | +4% shares |
| BROADCOM INC | AVGO | $29.89B | 5.5% | unchanged |
| ELI LILLY & CO | LLY | $26.40B | 4.9% | -2% shares |
| AMAZON COM INC | AMZN | $20.78B | 3.8% | -5% shares |
| ALPHABET INC | GOOGL | $16.29B | 3.0% | +3% shares |
| APPLE INC | AAPL | $15.08B | 2.8% | +22% shares |
| RTX CORPORATION | RTX | $13.96B | 2.6% | unchanged |
| META PLATFORMS INC | META | $11.80B | 2.2% | -25% shares |
| UBER TECHNOLOGIES INC | UBER | $9.27B | 1.7% | +3% shares |
| ALPHABET INC | GOOG | $8.82B | 1.6% | +3% shares |
| PHILIP MORRIS INTL INC | PM | $8.75B | 1.6% | +25% shares |
| APPLIED MATLS INC | AMAT | $8.41B | 1.6% | +120% shares |
| VERTEX PHARMACEUTICALS INC | VRTX | $7.85B | 1.4% | +5% shares |
| GE AEROSPACE | GE | $7.62B | 1.4% | -6% shares |
| JPMORGAN CHASE & CO. | JPM | $7.07B | 1.3% | -5% shares |
| STARBUCKS CORP | SBUX | $6.92B | 1.3% | -4% shares |
| MASTERCARD INCORPORATED | MA | $6.16B | 1.1% | +4% shares |
| ORACLE CORP | ORCL | $5.87B | 1.1% | +29% shares |
| ABBVIE INC | ABBV | $5.81B | 1.1% | unchanged |
| ROYAL CARIBBEAN GROUP | $5.63B | 1.0% | +5% shares | |
| CANADIAN NAT RES LTD | CNQ | $4.96B | 0.9% | +32% shares |
| ABBOTT LABS | ABT | $4.91B | 0.9% | unchanged |
| MERCADOLIBRE INC | MELI | $4.48B | 0.8% | +23% shares |
| LINDE PLC | $4.32B | 0.8% | +9% shares |
What changed since Q3 2025
Against the Q3 2025 filing, Capital Research Global Investors opened 32 new positions, added to 135, trimmed 130, left 137 unchanged and exited 31. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
- MDLN$620.94M
- FICO$516.61M
- GLXY$406.10M
- USB$296.38M
- NEBIUS GROUP N.V.$231.64M
- GPGI$166.83M
- NKE$165.78M
- MAKEMYTRIP LIMITED MAURITIUS$150.07M
and 24 more
Exited
- NVENT ELECTRIC PLCwas $379.47M
- CMGwas $378.10M
- ALB 7.25 03/01/27was $175.02M
- BRBRwas $172.31M
- LNWOwas $166.77M
- DXCMwas $159.32M
- ALwas $103.43M
- GENIUS SPORTS LIMITEDwas $97.42M
and 23 more
Other quarters
Source: SEC Form 13F-HR, accession 0001422848-26-000005, filed by Capital Research Global Investors. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.